Tobacco Giant Philip Morris Rethinks Pharma Dive, Mulls Vectura Stake Sale Amid Challenges: Report
Portfolio Pulse from Nabaparna Bhattacharya
Philip Morris International Inc is considering selling a stake in its UK-based Vectura pharmaceuticals unit. The tobacco company is exploring options to make the business work, including selling a majority or minority stake, a licensing or royalties deal, or a commercial partnership. The company faced challenges over the summer, incurring a $680 million charge related to its wellness and healthcare sector. Philip Morris is reportedly in talks with Deutsche Bank AG to strategize ways to boost its wellness and healthcare unit.
September 20, 2023 | 11:18 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Philip Morris is considering selling a stake in its Vectura unit, indicating challenges in its wellness and healthcare sector.
The news of Philip Morris considering selling a stake in its Vectura unit indicates challenges in its wellness and healthcare sector. This could potentially impact investor confidence and lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Philip Morris is reportedly in talks with Deutsche Bank AG to strategize ways to boost its wellness and healthcare unit.
Deutsche Bank is reportedly in talks with Philip Morris to strategize ways to boost its wellness and healthcare unit. While this could potentially lead to new business for Deutsche Bank, the impact on the bank's overall performance is likely to be limited.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50